Skip to main content
Erschienen in: Social Psychiatry and Psychiatric Epidemiology 7/2010

01.07.2010 | Original Paper

Cost-effectiveness analysis of an occupational therapy-led lifestyle approach and routine general practitioner’s care for panic disorder

verfasst von: Rodney A. Lambert, Paula Lorgelly, Ian Harvey, Fiona Poland

Erschienen in: Social Psychiatry and Psychiatric Epidemiology | Ausgabe 7/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

To assess the cost-effectiveness of an occupational therapy-led lifestyle approach to treating panic disorder in primary care compared with routine general practitioner’s (GP) care. The burden of mental health disorders is considerable. Cost-effective interventions are necessary to alleviate some of these burdens. Habitual lifestyle behaviours influence mood, although to date mainly single lifestyle factor trials have been conducted to examine the effects on anxiety.

Methods

An economic evaluation was conducted alongside an unblinded pragmatic randomised controlled trial with assessment at 5 and 10 months. Costs and consequences, as measured by the Beck anxiety inventory (BAI) and quality adjusted life years (QALYs), were compared using incremental cost-effectiveness ratios (ICERs).

Results

The occupational therapy-led lifestyle intervention was more costly than routine GP care at both 5 and 10 months. Significant outcome improvements were evident at 5 months when using the BAI, although these were not maintained at 10 months. Small differences in mean QALYs were found. The estimated ICER was £36 per BAI improvement for 5 months and £39 for 10 months, and £18,905 per QALY gained for 5 months and £8,283 for 10 months.

Conclusions

If the maximum willingness to pay per additional QALY is £30,000, then there is an 86% chance that a lifestyle intervention may be considered to be value-for-money over 10 months.
Literatur
1.
Zurück zum Zitat Alsene K, Deckert J, Sand P, de Wit H (2003) Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28:1694–1702CrossRefPubMed Alsene K, Deckert J, Sand P, de Wit H (2003) Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28:1694–1702CrossRefPubMed
2.
Zurück zum Zitat American Psychiatric Association (2000) Diagnostic & statistical manual of mental disorders; DSM-IV TR. American Psychiatric Association, Washington, DC American Psychiatric Association (2000) Diagnostic & statistical manual of mental disorders; DSM-IV TR. American Psychiatric Association, Washington, DC
3.
Zurück zum Zitat American Psychiatric Association (2000) Practice guidelines for the treatment of psychiatric disorders: compendium 2000. American Psychiatric Association, Washington, DC American Psychiatric Association (2000) Practice guidelines for the treatment of psychiatric disorders: compendium 2000. American Psychiatric Association, Washington, DC
4.
Zurück zum Zitat Andrews G (2003) Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia. Aust N Z J Psychiat 37:641 Andrews G (2003) Australian and New Zealand clinical practice guidelines for the treatment of panic disorder and agoraphobia. Aust N Z J Psychiat 37:641
5.
Zurück zum Zitat Asmundson GJ, Larsen DK, Stein MB (1998) Panic disorder and vestibular disturbance: an overview of empirical findings and clinical implications. J Psychosom Res 44:107–120CrossRefPubMed Asmundson GJ, Larsen DK, Stein MB (1998) Panic disorder and vestibular disturbance: an overview of empirical findings and clinical implications. J Psychosom Res 44:107–120CrossRefPubMed
6.
Zurück zum Zitat Barlow JH, Ellard DR, Hainsworth JM, Jones FR, Fisher A (2005) A review of self-management interventions for panic disorders, phobias and obsessive-compulsive disorders. Acta Psychiatr Scand 111:272–285CrossRefPubMed Barlow JH, Ellard DR, Hainsworth JM, Jones FR, Fisher A (2005) A review of self-management interventions for panic disorders, phobias and obsessive-compulsive disorders. Acta Psychiatr Scand 111:272–285CrossRefPubMed
7.
Zurück zum Zitat Beck AT, Steer RA (1993) Beck anxiety inventory manual. The Psychological Corporation, San Antonio Beck AT, Steer RA (1993) Beck anxiety inventory manual. The Psychological Corporation, San Antonio
9.
Zurück zum Zitat Biber B, Alkin T (1999) Panic disorder subtypes: differential responses to CO2 challenge. Am J Psychiatry 156:739–744PubMed Biber B, Alkin T (1999) Panic disorder subtypes: differential responses to CO2 challenge. Am J Psychiatry 156:739–744PubMed
10.
Zurück zum Zitat Bower P, Richards D, Lovell K (2001) The clinical and cost-effectiveness of self-help treatments for anxiety and depressive disorders in primary care: a systematic review. Br J Gen Pract 51:838–845PubMed Bower P, Richards D, Lovell K (2001) The clinical and cost-effectiveness of self-help treatments for anxiety and depressive disorders in primary care: a systematic review. Br J Gen Pract 51:838–845PubMed
11.
Zurück zum Zitat Brazier J, Roberts J, Tsuchiya A, Busschbach J (2004) A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 13:873–884CrossRefPubMed Brazier J, Roberts J, Tsuchiya A, Busschbach J (2004) A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 13:873–884CrossRefPubMed
12.
Zurück zum Zitat Briggs AH, Wonderling DE, Mooney CZ (1997) Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 6:327–340CrossRefPubMed Briggs AH, Wonderling DE, Mooney CZ (1997) Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ 6:327–340CrossRefPubMed
14.
Zurück zum Zitat Brown TA, DiNardo PA, Barlow DH (1994) Anxiety disorders interview schedule for DSM-IV (Adult version). Graywind Publications Incorporated, New York Brown TA, DiNardo PA, Barlow DH (1994) Anxiety disorders interview schedule for DSM-IV (Adult version). Graywind Publications Incorporated, New York
15.
Zurück zum Zitat Callaghan P (2004) Exercise: a neglected intervention in mental health care? J Psychiatr Ment Health Nurs 11:476–483CrossRefPubMed Callaghan P (2004) Exercise: a neglected intervention in mental health care? J Psychiatr Ment Health Nurs 11:476–483CrossRefPubMed
16.
Zurück zum Zitat Clark DM, Salkovskis PM, Hackmann A, Wells A, Ludgate J, Gelder M (1999) Brief cognitive therapy for panic disorder: a randomized controlled trial. J Consult Clin Psychol 67:583–589CrossRefPubMed Clark DM, Salkovskis PM, Hackmann A, Wells A, Ludgate J, Gelder M (1999) Brief cognitive therapy for panic disorder: a randomized controlled trial. J Consult Clin Psychol 67:583–589CrossRefPubMed
17.
Zurück zum Zitat Davids E, Muller MJ, Rollmann N, Burkart M, Regier-Klein E, Szegedi A, Benkert O, Maier W (2002) Syndrome profiles in alcoholism and panic disorder with or without agoraphobia: an explorative family study. Prog Neuropsychopharmacol Biol Psychiatry 26:1079–1087CrossRefPubMed Davids E, Muller MJ, Rollmann N, Burkart M, Regier-Klein E, Szegedi A, Benkert O, Maier W (2002) Syndrome profiles in alcoholism and panic disorder with or without agoraphobia: an explorative family study. Prog Neuropsychopharmacol Biol Psychiatry 26:1079–1087CrossRefPubMed
18.
Zurück zum Zitat Department of Health (1999) National service framework for mental health: modern standards & service models. Department of Health, London Department of Health (1999) National service framework for mental health: modern standards & service models. Department of Health, London
19.
Zurück zum Zitat Department of Health (2007) Health is global: proposal for a UK government-wide strategy. Department of Health, London Department of Health (2007) Health is global: proposal for a UK government-wide strategy. Department of Health, London
20.
Zurück zum Zitat Dolan P, Gudex C, Kind P, Williams A (1995) Social tariff for EuroQol : results from a UK general population survey. Centre for Health Economics, University of York, York Dolan P, Gudex C, Kind P, Williams A (1995) Social tariff for EuroQol : results from a UK general population survey. Centre for Health Economics, University of York, York
21.
Zurück zum Zitat Duncan CE (2003) Monthly index of medical specialities (MIMS). Haymarket Medical Publications Ltd, London Duncan CE (2003) Monthly index of medical specialities (MIMS). Haymarket Medical Publications Ltd, London
22.
Zurück zum Zitat Falk Dahl CA, Dahl AA (2009) Lifestyle and social network in individuals with high level of social phobia/anxiety symptoms: a community-based study. Soc Psychiatry Psychiatr Epidemiol (in press) Falk Dahl CA, Dahl AA (2009) Lifestyle and social network in individuals with high level of social phobia/anxiety symptoms: a community-based study. Soc Psychiatry Psychiatr Epidemiol (in press)
23.
Zurück zum Zitat Frank E, Shear MK, Rucci P, Banti S, Mauri M, Maser JD, Kupfer DJ, Miniati M, Fagiolini A, Cassano GB (2005) Cross-cultural validity of the structured clinical interview for panic-agoraphobic spectrum. Soc Psychiatry Psychiatr Epidemiol 40:283–290CrossRefPubMed Frank E, Shear MK, Rucci P, Banti S, Mauri M, Maser JD, Kupfer DJ, Miniati M, Fagiolini A, Cassano GB (2005) Cross-cultural validity of the structured clinical interview for panic-agoraphobic spectrum. Soc Psychiatry Psychiatr Epidemiol 40:283–290CrossRefPubMed
24.
Zurück zum Zitat Glick H, Doshi J, Sonnad S, Polsky D (2007) Transferability of the results from trials: economic evaluation in clinical trials. Oxford University Press, Oxford Glick H, Doshi J, Sonnad S, Polsky D (2007) Transferability of the results from trials: economic evaluation in clinical trials. Oxford University Press, Oxford
25.
Zurück zum Zitat Gulpek D, Bayraktar E, Akbay SP, Capaci K, Kayikcioglu M, Aliyev E, Soydas C (2004) Joint hypermobility syndrome and mitral valve prolapse in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 28:969–973CrossRefPubMed Gulpek D, Bayraktar E, Akbay SP, Capaci K, Kayikcioglu M, Aliyev E, Soydas C (2004) Joint hypermobility syndrome and mitral valve prolapse in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 28:969–973CrossRefPubMed
26.
Zurück zum Zitat Hamilton SP, Fyer AJ, Durner M, Heiman GA, Baisre DL, Hodge SE, Knowles JA, Weissman MM (2003) Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc Natl Acad Sci USA 100:2550–2555CrossRefPubMed Hamilton SP, Fyer AJ, Durner M, Heiman GA, Baisre DL, Hodge SE, Knowles JA, Weissman MM (2003) Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc Natl Acad Sci USA 100:2550–2555CrossRefPubMed
27.
Zurück zum Zitat Heuzenroeder L, Donnelly M, Haby MM, Mihalopoulos C, Rossell R, Carter R, Andrews G, Vos T (2004) Cost-effectiveness of psychological and pharmacological interventions for generalised anxiety disorder and panic disorder. Aust N Z J Psychiatry 38:602–612PubMed Heuzenroeder L, Donnelly M, Haby MM, Mihalopoulos C, Rossell R, Carter R, Andrews G, Vos T (2004) Cost-effectiveness of psychological and pharmacological interventions for generalised anxiety disorder and panic disorder. Aust N Z J Psychiatry 38:602–612PubMed
28.
Zurück zum Zitat Horwath E, Adams P, Wickramaratne P, Pine D, Weissman MM (1997) Panic disorder with smothering symptoms: evidence for increased risk in first-degree relatives. Depress Anxiety 6:147–153CrossRefPubMed Horwath E, Adams P, Wickramaratne P, Pine D, Weissman MM (1997) Panic disorder with smothering symptoms: evidence for increased risk in first-degree relatives. Depress Anxiety 6:147–153CrossRefPubMed
29.
Zurück zum Zitat Isensee B, Wittchen HU, Stein MB, Hofler M, Lieb R (2003) Smoking increases the risk of panic: findings from a prospective community study. Arch Gen Psychiatry 60:692–700CrossRefPubMed Isensee B, Wittchen HU, Stein MB, Hofler M, Lieb R (2003) Smoking increases the risk of panic: findings from a prospective community study. Arch Gen Psychiatry 60:692–700CrossRefPubMed
31.
Zurück zum Zitat Kaltenthaler E, Brazier J, De Nigris E, Tumur I, Ferriter M, Beverly C, Parry G, Rooney G, Sutcliffe P (2006) Computerized cognitive behavior therapy for depression and anxiety update: a systematic review and economic evaluation. Health Technol Assess 10:1–70 Kaltenthaler E, Brazier J, De Nigris E, Tumur I, Ferriter M, Beverly C, Parry G, Rooney G, Sutcliffe P (2006) Computerized cognitive behavior therapy for depression and anxiety update: a systematic review and economic evaluation. Health Technol Assess 10:1–70
32.
Zurück zum Zitat Kaltenthaler E, Shackley P, Stevens K, Beverley C, Parry G, Chilcott J (2002) A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety. Health Technol Assess 6:1–89PubMed Kaltenthaler E, Shackley P, Stevens K, Beverley C, Parry G, Chilcott J (2002) A systematic review and economic evaluation of computerised cognitive behaviour therapy for depression and anxiety. Health Technol Assess 6:1–89PubMed
33.
Zurück zum Zitat Katon W, Russo J, Sherbourne C, Stein MB, Craske M, Fan MY, Roy-Byrne P (2006) Incremental cost-effectiveness of a collaborative care intervention for panic disorder. Psychol Med 36:353–363CrossRefPubMed Katon W, Russo J, Sherbourne C, Stein MB, Craske M, Fan MY, Roy-Byrne P (2006) Incremental cost-effectiveness of a collaborative care intervention for panic disorder. Psychol Med 36:353–363CrossRefPubMed
34.
Zurück zum Zitat Koh KB, Lee Y (2004) Reduced anxiety level by therapeutic interventions and cell-mediated immunity in panic disorder patients. Psychother Psychosom 73:286–292CrossRefPubMed Koh KB, Lee Y (2004) Reduced anxiety level by therapeutic interventions and cell-mediated immunity in panic disorder patients. Psychother Psychosom 73:286–292CrossRefPubMed
35.
Zurück zum Zitat Kumano H, Kaiya H, Yoshiuchi K, Yamanaka G, Sasaki T, Kuboki T (2004) Comorbidity of irritable bowel syndrome, panic disorder, and agoraphobia in a Japanese representative sample. Am J Gastroenterol 99:370–376CrossRefPubMed Kumano H, Kaiya H, Yoshiuchi K, Yamanaka G, Sasaki T, Kuboki T (2004) Comorbidity of irritable bowel syndrome, panic disorder, and agoraphobia in a Japanese representative sample. Am J Gastroenterol 99:370–376CrossRefPubMed
36.
Zurück zum Zitat Lambert R, Caan W, McVicar A (2008) Influences of lifestyle and general practice (GP) care on the symptom profile of people with panic disorder. J Public Ment Health 7:18–24 Lambert R, Caan W, McVicar A (2008) Influences of lifestyle and general practice (GP) care on the symptom profile of people with panic disorder. J Public Ment Health 7:18–24
37.
Zurück zum Zitat Lambert RA, Harvey I, Poland F (2007) A pragmatic, unblinded randomised controlled trial comparing an occupational therapy-led lifestyle approach and routine GP care for panic disorder treatment in primary care. J Affect Disord 99:63–71CrossRefPubMed Lambert RA, Harvey I, Poland F (2007) A pragmatic, unblinded randomised controlled trial comparing an occupational therapy-led lifestyle approach and routine GP care for panic disorder treatment in primary care. J Affect Disord 99:63–71CrossRefPubMed
38.
Zurück zum Zitat Manca A, Hawkins N, Sculpher MJ (2005) Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 14:487–496CrossRefPubMed Manca A, Hawkins N, Sculpher MJ (2005) Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ 14:487–496CrossRefPubMed
39.
Zurück zum Zitat Mann R, Gilbody S, Richards D (2009) Putting the ‘Q’ in depression QALYs: a comparison of utility measurement using EQ-5D and SF-6D health related quality of life measures. Soc Psychiatry Psychiatr Epidemiol 44:569–578CrossRefPubMed Mann R, Gilbody S, Richards D (2009) Putting the ‘Q’ in depression QALYs: a comparison of utility measurement using EQ-5D and SF-6D health related quality of life measures. Soc Psychiatry Psychiatr Epidemiol 44:569–578CrossRefPubMed
40.
Zurück zum Zitat March JS, Silva SG, Compton S, Shapiro M, Califf R, Krishnan R (2005) The case for practical clinical trials in psychiatry. Am J Psychiatry 162:836–846CrossRefPubMed March JS, Silva SG, Compton S, Shapiro M, Califf R, Krishnan R (2005) The case for practical clinical trials in psychiatry. Am J Psychiatry 162:836–846CrossRefPubMed
41.
Zurück zum Zitat Marciniak MD, Lage MJ, Dunayevich E, Russell JM, Bowman L, Landbloom RP, Levine LR (2005) The cost of treating anxiety: the medical and demographic correlates that impact total medical costs. Depress Anxiety 21:178–184CrossRefPubMed Marciniak MD, Lage MJ, Dunayevich E, Russell JM, Bowman L, Landbloom RP, Levine LR (2005) The cost of treating anxiety: the medical and demographic correlates that impact total medical costs. Depress Anxiety 21:178–184CrossRefPubMed
42.
Zurück zum Zitat Matthews JN, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300:230–235CrossRefPubMed Matthews JN, Altman DG, Campbell MJ, Royston P (1990) Analysis of serial measurements in medical research. BMJ 300:230–235CrossRefPubMed
43.
Zurück zum Zitat Maunder RG (1998) Panic disorder associated with gastrointestinal disease: review and hypotheses. J Psychosom Res 44:91–105CrossRefPubMed Maunder RG (1998) Panic disorder associated with gastrointestinal disease: review and hypotheses. J Psychosom Res 44:91–105CrossRefPubMed
44.
Zurück zum Zitat McCrone P, Knapp M, Proudfoot J, Ryden C, Cavanagh K, Shapiro DA, Ilson S, Gray JA, Goldberg D, Mann A, Marks I, Everitt B, Tylee A (2004) Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. Br J Psychiatry 185:55–62CrossRefPubMed McCrone P, Knapp M, Proudfoot J, Ryden C, Cavanagh K, Shapiro DA, Ilson S, Gray JA, Goldberg D, Mann A, Marks I, Everitt B, Tylee A (2004) Cost-effectiveness of computerised cognitive-behavioural therapy for anxiety and depression in primary care: randomised controlled trial. Br J Psychiatry 185:55–62CrossRefPubMed
45.
Zurück zum Zitat McHugh RK, Otto MW, Barlow DH, Gorman JM, Shear MK, Woods SW (2007) Cost-efficacy of individual and combined treatments for panic disorder. J Clin Psychiatry 68:1038–1044CrossRefPubMed McHugh RK, Otto MW, Barlow DH, Gorman JM, Shear MK, Woods SW (2007) Cost-efficacy of individual and combined treatments for panic disorder. J Clin Psychiatry 68:1038–1044CrossRefPubMed
46.
Zurück zum Zitat Mulder M, Ranchor AV, Sanderman R, Bouma J, van den Heuvel WJ (1998) The stability of lifestyle behaviour. Int J Epidemiol 27:199–207CrossRefPubMed Mulder M, Ranchor AV, Sanderman R, Bouma J, van den Heuvel WJ (1998) The stability of lifestyle behaviour. Int J Epidemiol 27:199–207CrossRefPubMed
47.
Zurück zum Zitat Muller V, Birbaumer N, Preissl H, Braun C, Lang F (2002) Effects of water on cortical excitability in humans. Eur J Neurosci 15:528–538CrossRefPubMed Muller V, Birbaumer N, Preissl H, Braun C, Lang F (2002) Effects of water on cortical excitability in humans. Eur J Neurosci 15:528–538CrossRefPubMed
48.
Zurück zum Zitat Nadiga DN, Hensley PL, Uhlenhuth EH (2003) Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder. Depress Anxiety 17:58–64CrossRefPubMed Nadiga DN, Hensley PL, Uhlenhuth EH (2003) Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder. Depress Anxiety 17:58–64CrossRefPubMed
49.
Zurück zum Zitat Netten A, Rees T, Harrison G, PSSRU (2002) Unit costs of health and social care 2002. Personal Social Services Research Unit, Canterbury Netten A, Rees T, Harrison G, PSSRU (2002) Unit costs of health and social care 2002. Personal Social Services Research Unit, Canterbury
50.
Zurück zum Zitat National Institute for Health and Clinical Excellence (NICE) (2004) Clinical guidelines for the management of panic disorder and generalised anxiety disorder: consultation document. ScHARR, University of Sheffield National Institute for Health and Clinical Excellence (NICE) (2004) Clinical guidelines for the management of panic disorder and generalised anxiety disorder: consultation document. ScHARR, University of Sheffield
51.
Zurück zum Zitat Papakostas GI, Ongur D, Iosifescu DV, Mischoulon D, Fava M (2004) Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. Eur Neuropsychopharmacol 14:135–142CrossRefPubMed Papakostas GI, Ongur D, Iosifescu DV, Mischoulon D, Fava M (2004) Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. Eur Neuropsychopharmacol 14:135–142CrossRefPubMed
52.
Zurück zum Zitat Patel A, Knapp M, Evans A, Perez I, Kalra L (2004) Training care givers of stroke patients: economic evaluation. BMJ 328:1102CrossRefPubMed Patel A, Knapp M, Evans A, Perez I, Kalra L (2004) Training care givers of stroke patients: economic evaluation. BMJ 328:1102CrossRefPubMed
53.
Zurück zum Zitat Perna G, Dario A, Caldirola D, Stefania B, Cesarani A, Bellodi L (2001) Panic disorder: the role of the balance system. J Psychiatr Res 35:279–286CrossRefPubMed Perna G, Dario A, Caldirola D, Stefania B, Cesarani A, Bellodi L (2001) Panic disorder: the role of the balance system. J Psychiatr Res 35:279–286CrossRefPubMed
54.
Zurück zum Zitat Raftery J (2001) NICE: faster access to modern treatments? Analysis of guidance on health technologies. BMJ 323:1300–1303CrossRefPubMed Raftery J (2001) NICE: faster access to modern treatments? Analysis of guidance on health technologies. BMJ 323:1300–1303CrossRefPubMed
55.
Zurück zum Zitat Roberge P, Marchand A, Reinharz D, Savard P (2008) Cognitive-behavioral treatment for panic disorder with agoraphobia: a randomized, controlled trial and cost-effectiveness analysis. Behav Modif 32:333–351CrossRefPubMed Roberge P, Marchand A, Reinharz D, Savard P (2008) Cognitive-behavioral treatment for panic disorder with agoraphobia: a randomized, controlled trial and cost-effectiveness analysis. Behav Modif 32:333–351CrossRefPubMed
56.
Zurück zum Zitat Slattery MJ, Klein DF, Mannuzza S, Moulton JLIII, Pine DS, Klein RG (2002) Relationship between separation anxiety disorder, parental panic disorder, and atopic disorders in children: a controlled high-risk study. J Am Acad Child Adolesc Psychiatry 41:947–954CrossRefPubMed Slattery MJ, Klein DF, Mannuzza S, Moulton JLIII, Pine DS, Klein RG (2002) Relationship between separation anxiety disorder, parental panic disorder, and atopic disorders in children: a controlled high-risk study. J Am Acad Child Adolesc Psychiatry 41:947–954CrossRefPubMed
57.
Zurück zum Zitat Smoller JW, Gardner-Schuster E, Covino J (2008) The genetic basis of panic and phobic anxiety disorders. Am J Med Genet C Semin Med Genet 148C:118–126CrossRefPubMed Smoller JW, Gardner-Schuster E, Covino J (2008) The genetic basis of panic and phobic anxiety disorders. Am J Med Genet C Semin Med Genet 148C:118–126CrossRefPubMed
58.
Zurück zum Zitat The Sainsbury Centre for Mental Health (2003) The economic and social costs of mental illness. Policy Paper 3. The Sainsbury Centre for Mental Health, London The Sainsbury Centre for Mental Health (2003) The economic and social costs of mental illness. Policy Paper 3. The Sainsbury Centre for Mental Health, London
59.
Zurück zum Zitat van Hout BA, Al MJ, Gordon GS, Rutten FF (1994) Costs, effects and C/E-ratios alongside a clinical trial. Health Econ 3:309–319CrossRefPubMed van Hout BA, Al MJ, Gordon GS, Rutten FF (1994) Costs, effects and C/E-ratios alongside a clinical trial. Health Econ 3:309–319CrossRefPubMed
60.
Zurück zum Zitat Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen HU, Yeh EK (1997) The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 54:305–309PubMed Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen HU, Yeh EK (1997) The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 54:305–309PubMed
61.
Zurück zum Zitat Weissman MM, Fyer AJ, Haghighi F, Heiman G, Deng Z, Hen R, Hodge SE, Knowles JA (2000) Potential panic disorder syndrome: clinical and genetic linkage evidence. Am J Med Genet 96:24–35CrossRefPubMed Weissman MM, Fyer AJ, Haghighi F, Heiman G, Deng Z, Hen R, Hodge SE, Knowles JA (2000) Potential panic disorder syndrome: clinical and genetic linkage evidence. Am J Med Genet 96:24–35CrossRefPubMed
62.
Zurück zum Zitat WHO (2004) Prevention of mental disorders: effective interventions and policy options. World Health Organisation, Geneva WHO (2004) Prevention of mental disorders: effective interventions and policy options. World Health Organisation, Geneva
63.
Zurück zum Zitat Yeragani VK, Tancer M, Uhde T (2003) Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder. Psychiatry Res 121:185–196CrossRefPubMed Yeragani VK, Tancer M, Uhde T (2003) Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic disorder. Psychiatry Res 121:185–196CrossRefPubMed
Metadaten
Titel
Cost-effectiveness analysis of an occupational therapy-led lifestyle approach and routine general practitioner’s care for panic disorder
verfasst von
Rodney A. Lambert
Paula Lorgelly
Ian Harvey
Fiona Poland
Publikationsdatum
01.07.2010
Verlag
Springer-Verlag
Erschienen in
Social Psychiatry and Psychiatric Epidemiology / Ausgabe 7/2010
Print ISSN: 0933-7954
Elektronische ISSN: 1433-9285
DOI
https://doi.org/10.1007/s00127-009-0114-5

Weitere Artikel der Ausgabe 7/2010

Social Psychiatry and Psychiatric Epidemiology 7/2010 Zur Ausgabe

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.